// App-Quantinova.ai

: 3 The Unique Physiochemical Profile of Co-Crystal of Tramadol-Celecoxib Optimizes Pharmacokinetic and Pharmacodynamic Synchronization: Structural Properties, Differential Dissolution Behavior and Pharmacokinetic Parameters

Researchers

Presenter

  • Carmen Almansa

Principal Investigators

  • N/A

Medical Centers

  • Esteve Pharmaceuticals S.A., Barcelona, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • E58425

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

  • Pharmacodynamics

  • Cross Over

  • Open Label

  • Single Center

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved